← Eichor
Study identifier: NCT06980480 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma

Condition: Multiple Myeloma · Secondary Immunodeficiency  ·  Sponsor: Takeda

PhasePhase 3
Planned participants183
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Multiple myeloma is a cancer of the plasma cells in the bone marrow. The main aim of this study is to learn how well the Immune Globulin Infusion (human), 10 percentage (%) (IGI, 10%) can help prevent infections in participants with multiple myeloma receiving B-cell maturation antigen (BCMA) x cluster of differentiation 3 (CD3) directed bispecific antibody therapy. Participants will be randomly assigned to one of two groups: 1. Primary infection prevention group: They will receive IGI, 10% for 12 months. 2. Secondary infection prevention group: They will only receive IGI, 10% if they develop a serious infection during the 12 months study period. During the study, participants will visit their study clinic 15 times (for 4-week dosing interval) or 19 times (for 3-week dosing interval) and their total participation duration will be up to 14 months (including screening period approximately 8 weeks).

This description comes directly from the study's public registry record.

Talk to the study team

Takeda Contact  ·  +1-877-825-3327  ·  medinfoUS@takeda.com

Always discuss trial participation with your own doctor first.

Locations (42)

Infirmary Health - Diagnostic & Medical Clinic (DMC)Mobile, Alabama, United StatesRecruiting
Chao Family Comprehensive Cancer Center UCIOrange, California, United StatesRecruiting
University of KansasWestwood, Kansas, United StatesRecruiting
University of Maryland | Greenebaum Cancer CenterBaltimore, Maryland, United StatesRecruiting
Henry Ford Health SystemDetroit, Michigan, United StatesRecruiting
Washington University School of MedicineSt Louis, Missouri, United StatesRecruiting
New York Oncology HematologyAlbany, New York, United StatesRecruiting
St George Private HospitalKogarah, New South Wales, AustraliaRecruiting
Townsville HospitalDouglas, Queensland, AustraliaRecruiting
Western Health - Sunshine HospitalSt Albans, Victoria, AustraliaRecruiting
Fiona Stanley HospitalMurdoch, Western Australia, AustraliaRecruiting
St Vincents Hospital MelbourneMelbourne, AustraliaRecruiting

+ 30 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06980480